drugset / Trial / NCT01573052

Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

NCT01573052

Phase 4 Completed 26 enrolled VA Salt Lake City Health Care System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, double-blind controlled trial comparing treatment outcomes between chlordiazepoxide, or gabapentin to treat alcohol withdrawal syndrome in alcohol dependent veteran subjects. The objective of this trial is to compare the safety and effectiveness of these two medications. Intervention is a fixed dose taper of chlordiazepoxide, or gabapentin over 6 days. Subjects will be evaluated for 7-10 days to monitor alcohol abstinence, withdrawal severity scores, adverse events including ataxia, sedation, cognitive function and alcohol craving.

Timeline

Start
2004-03
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg Oral
Comparator chlordiazepoxide Small molecule 100 mg Oral

Indications